nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—Hexylcaine—SCN10A—skin cancer	0.0124	1	CrCbGaD
Methylphenidate—Anaemia—Dactinomycin—skin cancer	0.000867	0.000878	CcSEcCtD
Methylphenidate—Liver function test abnormal—Docetaxel—skin cancer	0.000865	0.000876	CcSEcCtD
Methylphenidate—Vomiting—Vemurafenib—skin cancer	0.000861	0.000872	CcSEcCtD
Methylphenidate—Alopecia—Temozolomide—skin cancer	0.000861	0.000872	CcSEcCtD
Methylphenidate—Chest pain—Bleomycin—skin cancer	0.000856	0.000867	CcSEcCtD
Methylphenidate—Myalgia—Bleomycin—skin cancer	0.000856	0.000867	CcSEcCtD
Methylphenidate—Abdominal pain upper—Docetaxel—skin cancer	0.000855	0.000866	CcSEcCtD
Methylphenidate—Rash—Vemurafenib—skin cancer	0.000854	0.000865	CcSEcCtD
Methylphenidate—Mental disorder—Temozolomide—skin cancer	0.000854	0.000864	CcSEcCtD
Methylphenidate—Dermatitis—Vemurafenib—skin cancer	0.000853	0.000864	CcSEcCtD
Methylphenidate—Hypersensitivity—Imiquimod—skin cancer	0.000851	0.000862	CcSEcCtD
Methylphenidate—Headache—Vemurafenib—skin cancer	0.000848	0.000859	CcSEcCtD
Methylphenidate—Malnutrition—Temozolomide—skin cancer	0.000848	0.000859	CcSEcCtD
Methylphenidate—Erythema—Temozolomide—skin cancer	0.000848	0.000859	CcSEcCtD
Methylphenidate—Breast disorder—Docetaxel—skin cancer	0.000846	0.000857	CcSEcCtD
Methylphenidate—Discomfort—Bleomycin—skin cancer	0.000846	0.000856	CcSEcCtD
Methylphenidate—Malaise—Dactinomycin—skin cancer	0.000846	0.000856	CcSEcCtD
Methylphenidate—Cramp muscle—Docetaxel—skin cancer	0.000843	0.000854	CcSEcCtD
Methylphenidate—Leukopenia—Dactinomycin—skin cancer	0.000839	0.00085	CcSEcCtD
Methylphenidate—Nasopharyngitis—Docetaxel—skin cancer	0.000838	0.000848	CcSEcCtD
Methylphenidate—Asthenia—Imiquimod—skin cancer	0.000829	0.000839	CcSEcCtD
Methylphenidate—Confusional state—Bleomycin—skin cancer	0.000827	0.000838	CcSEcCtD
Methylphenidate—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000826	0.000836	CcSEcCtD
Methylphenidate—Oedema—Bleomycin—skin cancer	0.000821	0.000831	CcSEcCtD
Methylphenidate—Anaphylactic shock—Bleomycin—skin cancer	0.000821	0.000831	CcSEcCtD
Methylphenidate—Back pain—Temozolomide—skin cancer	0.00082	0.000831	CcSEcCtD
Methylphenidate—Pruritus—Imiquimod—skin cancer	0.000817	0.000827	CcSEcCtD
Methylphenidate—Infection—Bleomycin—skin cancer	0.000815	0.000825	CcSEcCtD
Methylphenidate—Nausea—Vemurafenib—skin cancer	0.000804	0.000815	CcSEcCtD
Methylphenidate—Thrombocytopenia—Bleomycin—skin cancer	0.000803	0.000813	CcSEcCtD
Methylphenidate—Arrhythmia—Fluorouracil—skin cancer	0.000802	0.000812	CcSEcCtD
Methylphenidate—Vision blurred—Temozolomide—skin cancer	0.000799	0.000809	CcSEcCtD
Methylphenidate—Myalgia—Dactinomycin—skin cancer	0.000798	0.000808	CcSEcCtD
Methylphenidate—Tremor—Temozolomide—skin cancer	0.000795	0.000805	CcSEcCtD
Methylphenidate—Alopecia—Fluorouracil—skin cancer	0.000793	0.000803	CcSEcCtD
Methylphenidate—Diarrhoea—Imiquimod—skin cancer	0.00079	0.0008	CcSEcCtD
Methylphenidate—Discomfort—Dactinomycin—skin cancer	0.000789	0.000799	CcSEcCtD
Methylphenidate—Angina pectoris—Docetaxel—skin cancer	0.000789	0.000798	CcSEcCtD
Methylphenidate—Ill-defined disorder—Temozolomide—skin cancer	0.000787	0.000797	CcSEcCtD
Methylphenidate—Anaemia—Temozolomide—skin cancer	0.000784	0.000794	CcSEcCtD
Methylphenidate—Anorexia—Bleomycin—skin cancer	0.000782	0.000792	CcSEcCtD
Methylphenidate—Erythema—Fluorouracil—skin cancer	0.000781	0.000791	CcSEcCtD
Methylphenidate—Agitation—Temozolomide—skin cancer	0.000779	0.000789	CcSEcCtD
Methylphenidate—Angioedema—Temozolomide—skin cancer	0.000775	0.000785	CcSEcCtD
Methylphenidate—Pancytopenia—Docetaxel—skin cancer	0.000769	0.000778	CcSEcCtD
Methylphenidate—Oedema—Dactinomycin—skin cancer	0.000765	0.000775	CcSEcCtD
Methylphenidate—Malaise—Temozolomide—skin cancer	0.000765	0.000774	CcSEcCtD
Methylphenidate—Dizziness—Imiquimod—skin cancer	0.000764	0.000773	CcSEcCtD
Methylphenidate—Vertigo—Temozolomide—skin cancer	0.000762	0.000772	CcSEcCtD
Methylphenidate—Infection—Dactinomycin—skin cancer	0.00076	0.00077	CcSEcCtD
Methylphenidate—Leukopenia—Temozolomide—skin cancer	0.000759	0.000769	CcSEcCtD
Methylphenidate—Palpitations—Temozolomide—skin cancer	0.00075	0.000759	CcSEcCtD
Methylphenidate—Thrombocytopenia—Dactinomycin—skin cancer	0.000749	0.000759	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000748	0.000757	CcSEcCtD
Methylphenidate—Cough—Temozolomide—skin cancer	0.00074	0.000749	CcSEcCtD
Methylphenidate—Paraesthesia—Bleomycin—skin cancer	0.000737	0.000746	CcSEcCtD
Methylphenidate—Weight increased—Docetaxel—skin cancer	0.000737	0.000746	CcSEcCtD
Methylphenidate—Vision blurred—Fluorouracil—skin cancer	0.000736	0.000746	CcSEcCtD
Methylphenidate—Convulsion—Temozolomide—skin cancer	0.000735	0.000744	CcSEcCtD
Methylphenidate—Vomiting—Imiquimod—skin cancer	0.000734	0.000744	CcSEcCtD
Methylphenidate—Weight decreased—Docetaxel—skin cancer	0.000732	0.000742	CcSEcCtD
Methylphenidate—Hypertension—Temozolomide—skin cancer	0.000732	0.000741	CcSEcCtD
Methylphenidate—Dyspnoea—Bleomycin—skin cancer	0.000732	0.000741	CcSEcCtD
Methylphenidate—Anorexia—Dactinomycin—skin cancer	0.000729	0.000739	CcSEcCtD
Methylphenidate—Rash—Imiquimod—skin cancer	0.000728	0.000737	CcSEcCtD
Methylphenidate—Dermatitis—Imiquimod—skin cancer	0.000728	0.000737	CcSEcCtD
Methylphenidate—Pneumonia—Docetaxel—skin cancer	0.000726	0.000735	CcSEcCtD
Methylphenidate—Headache—Imiquimod—skin cancer	0.000724	0.000733	CcSEcCtD
Methylphenidate—Anaemia—Fluorouracil—skin cancer	0.000722	0.000731	CcSEcCtD
Methylphenidate—Arthralgia—Temozolomide—skin cancer	0.000722	0.000731	CcSEcCtD
Methylphenidate—Myalgia—Temozolomide—skin cancer	0.000722	0.000731	CcSEcCtD
Methylphenidate—Infestation—Docetaxel—skin cancer	0.000722	0.000731	CcSEcCtD
Methylphenidate—Infestation NOS—Docetaxel—skin cancer	0.000722	0.000731	CcSEcCtD
Methylphenidate—Anxiety—Temozolomide—skin cancer	0.00072	0.000729	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000717	0.000726	CcSEcCtD
Methylphenidate—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000716	0.000725	CcSEcCtD
Methylphenidate—Discomfort—Temozolomide—skin cancer	0.000713	0.000722	CcSEcCtD
Methylphenidate—Decreased appetite—Bleomycin—skin cancer	0.000713	0.000722	CcSEcCtD
Methylphenidate—Acute coronary syndrome—Docetaxel—skin cancer	0.000711	0.00072	CcSEcCtD
Methylphenidate—Myocardial infarction—Docetaxel—skin cancer	0.000707	0.000716	CcSEcCtD
Methylphenidate—Dry mouth—Temozolomide—skin cancer	0.000706	0.000715	CcSEcCtD
Methylphenidate—Pain—Bleomycin—skin cancer	0.000702	0.000711	CcSEcCtD
Methylphenidate—Conjunctivitis—Docetaxel—skin cancer	0.000702	0.00071	CcSEcCtD
Methylphenidate—Leukopenia—Fluorouracil—skin cancer	0.000699	0.000708	CcSEcCtD
Methylphenidate—Confusional state—Temozolomide—skin cancer	0.000698	0.000707	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000697	0.000706	CcSEcCtD
Methylphenidate—Anaphylactic shock—Temozolomide—skin cancer	0.000692	0.000701	CcSEcCtD
Methylphenidate—Oedema—Temozolomide—skin cancer	0.000692	0.000701	CcSEcCtD
Methylphenidate—Infection—Temozolomide—skin cancer	0.000688	0.000696	CcSEcCtD
Methylphenidate—Nausea—Imiquimod—skin cancer	0.000686	0.000695	CcSEcCtD
Methylphenidate—Hepatobiliary disease—Docetaxel—skin cancer	0.000683	0.000691	CcSEcCtD
Methylphenidate—Epistaxis—Docetaxel—skin cancer	0.000681	0.000689	CcSEcCtD
Methylphenidate—Nervous system disorder—Temozolomide—skin cancer	0.000679	0.000687	CcSEcCtD
Methylphenidate—Thrombocytopenia—Temozolomide—skin cancer	0.000678	0.000686	CcSEcCtD
Methylphenidate—Convulsion—Fluorouracil—skin cancer	0.000677	0.000686	CcSEcCtD
Methylphenidate—Feeling abnormal—Bleomycin—skin cancer	0.000676	0.000685	CcSEcCtD
Methylphenidate—Skin disorder—Temozolomide—skin cancer	0.000672	0.000681	CcSEcCtD
Methylphenidate—Hyperhidrosis—Temozolomide—skin cancer	0.000669	0.000678	CcSEcCtD
Methylphenidate—Myalgia—Fluorouracil—skin cancer	0.000665	0.000674	CcSEcCtD
Methylphenidate—Chest pain—Fluorouracil—skin cancer	0.000665	0.000674	CcSEcCtD
Methylphenidate—Decreased appetite—Dactinomycin—skin cancer	0.000665	0.000674	CcSEcCtD
Methylphenidate—Fatigue—Dactinomycin—skin cancer	0.00066	0.000668	CcSEcCtD
Methylphenidate—Anorexia—Temozolomide—skin cancer	0.00066	0.000668	CcSEcCtD
Methylphenidate—Discomfort—Fluorouracil—skin cancer	0.000657	0.000666	CcSEcCtD
Methylphenidate—Pain—Dactinomycin—skin cancer	0.000654	0.000663	CcSEcCtD
Methylphenidate—Urticaria—Bleomycin—skin cancer	0.000652	0.00066	CcSEcCtD
Methylphenidate—Haemoglobin—Docetaxel—skin cancer	0.000651	0.000659	CcSEcCtD
Methylphenidate—Rhinitis—Docetaxel—skin cancer	0.00065	0.000658	CcSEcCtD
Methylphenidate—Body temperature increased—Bleomycin—skin cancer	0.000649	0.000657	CcSEcCtD
Methylphenidate—Haemorrhage—Docetaxel—skin cancer	0.000648	0.000656	CcSEcCtD
Methylphenidate—Confusional state—Fluorouracil—skin cancer	0.000643	0.000651	CcSEcCtD
Methylphenidate—Pharyngitis—Docetaxel—skin cancer	0.000643	0.000651	CcSEcCtD
Methylphenidate—Urinary tract disorder—Docetaxel—skin cancer	0.00064	0.000648	CcSEcCtD
Methylphenidate—Oedema—Fluorouracil—skin cancer	0.000638	0.000646	CcSEcCtD
Methylphenidate—Anaphylactic shock—Fluorouracil—skin cancer	0.000638	0.000646	CcSEcCtD
Methylphenidate—Connective tissue disorder—Docetaxel—skin cancer	0.000637	0.000645	CcSEcCtD
Methylphenidate—Urethral disorder—Docetaxel—skin cancer	0.000635	0.000643	CcSEcCtD
Methylphenidate—Infection—Fluorouracil—skin cancer	0.000634	0.000642	CcSEcCtD
Methylphenidate—Feeling abnormal—Dactinomycin—skin cancer	0.000631	0.000639	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000631	0.000639	CcSEcCtD
Methylphenidate—Insomnia—Temozolomide—skin cancer	0.000626	0.000634	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Dactinomycin—skin cancer	0.000626	0.000634	CcSEcCtD
Methylphenidate—Nervous system disorder—Fluorouracil—skin cancer	0.000625	0.000633	CcSEcCtD
Methylphenidate—Thrombocytopenia—Fluorouracil—skin cancer	0.000624	0.000632	CcSEcCtD
Methylphenidate—Visual impairment—Docetaxel—skin cancer	0.000624	0.000632	CcSEcCtD
Methylphenidate—Tachycardia—Fluorouracil—skin cancer	0.000622	0.00063	CcSEcCtD
Methylphenidate—Paraesthesia—Temozolomide—skin cancer	0.000622	0.000629	CcSEcCtD
Methylphenidate—Dyspnoea—Temozolomide—skin cancer	0.000617	0.000625	CcSEcCtD
Methylphenidate—Somnolence—Temozolomide—skin cancer	0.000615	0.000623	CcSEcCtD
Methylphenidate—Erythema multiforme—Docetaxel—skin cancer	0.000613	0.00062	CcSEcCtD
Methylphenidate—Dyspepsia—Temozolomide—skin cancer	0.000609	0.000617	CcSEcCtD
Methylphenidate—Anorexia—Fluorouracil—skin cancer	0.000608	0.000616	CcSEcCtD
Methylphenidate—Eye disorder—Docetaxel—skin cancer	0.000605	0.000613	CcSEcCtD
Methylphenidate—Abdominal pain—Dactinomycin—skin cancer	0.000605	0.000613	CcSEcCtD
Methylphenidate—Body temperature increased—Dactinomycin—skin cancer	0.000605	0.000613	CcSEcCtD
Methylphenidate—Hypersensitivity—Bleomycin—skin cancer	0.000605	0.000612	CcSEcCtD
Methylphenidate—Decreased appetite—Temozolomide—skin cancer	0.000602	0.000609	CcSEcCtD
Methylphenidate—Cardiac disorder—Docetaxel—skin cancer	0.000601	0.000609	CcSEcCtD
Methylphenidate—Flushing—Docetaxel—skin cancer	0.000601	0.000609	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Temozolomide—skin cancer	0.000598	0.000605	CcSEcCtD
Methylphenidate—Fatigue—Temozolomide—skin cancer	0.000597	0.000604	CcSEcCtD
Methylphenidate—Pain—Temozolomide—skin cancer	0.000592	0.000599	CcSEcCtD
Methylphenidate—Constipation—Temozolomide—skin cancer	0.000592	0.000599	CcSEcCtD
Methylphenidate—Asthenia—Bleomycin—skin cancer	0.000589	0.000596	CcSEcCtD
Methylphenidate—Angiopathy—Docetaxel—skin cancer	0.000588	0.000595	CcSEcCtD
Methylphenidate—Immune system disorder—Docetaxel—skin cancer	0.000585	0.000593	CcSEcCtD
Methylphenidate—Mediastinal disorder—Docetaxel—skin cancer	0.000584	0.000591	CcSEcCtD
Methylphenidate—Chills—Docetaxel—skin cancer	0.000581	0.000589	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000581	0.000588	CcSEcCtD
Methylphenidate—Pruritus—Bleomycin—skin cancer	0.000581	0.000588	CcSEcCtD
Methylphenidate—Arrhythmia—Docetaxel—skin cancer	0.000579	0.000586	CcSEcCtD
Methylphenidate—Insomnia—Fluorouracil—skin cancer	0.000577	0.000584	CcSEcCtD
Methylphenidate—Paraesthesia—Fluorouracil—skin cancer	0.000573	0.00058	CcSEcCtD
Methylphenidate—Alopecia—Docetaxel—skin cancer	0.000573	0.00058	CcSEcCtD
Methylphenidate—Feeling abnormal—Temozolomide—skin cancer	0.00057	0.000578	CcSEcCtD
Methylphenidate—Dyspnoea—Fluorouracil—skin cancer	0.000569	0.000576	CcSEcCtD
Methylphenidate—Mental disorder—Docetaxel—skin cancer	0.000568	0.000575	CcSEcCtD
Methylphenidate—Somnolence—Fluorouracil—skin cancer	0.000567	0.000574	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Temozolomide—skin cancer	0.000566	0.000573	CcSEcCtD
Methylphenidate—Erythema—Docetaxel—skin cancer	0.000564	0.000571	CcSEcCtD
Methylphenidate—Malnutrition—Docetaxel—skin cancer	0.000564	0.000571	CcSEcCtD
Methylphenidate—Hypersensitivity—Dactinomycin—skin cancer	0.000564	0.000571	CcSEcCtD
Methylphenidate—Dyspepsia—Fluorouracil—skin cancer	0.000561	0.000568	CcSEcCtD
Methylphenidate—Decreased appetite—Fluorouracil—skin cancer	0.000554	0.000561	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000551	0.000558	CcSEcCtD
Methylphenidate—Urticaria—Temozolomide—skin cancer	0.00055	0.000557	CcSEcCtD
Methylphenidate—Asthenia—Dactinomycin—skin cancer	0.000549	0.000556	CcSEcCtD
Methylphenidate—Abdominal pain—Temozolomide—skin cancer	0.000547	0.000554	CcSEcCtD
Methylphenidate—Body temperature increased—Temozolomide—skin cancer	0.000547	0.000554	CcSEcCtD
Methylphenidate—Back pain—Docetaxel—skin cancer	0.000546	0.000552	CcSEcCtD
Methylphenidate—Pain—Fluorouracil—skin cancer	0.000545	0.000552	CcSEcCtD
Methylphenidate—Muscle spasms—Docetaxel—skin cancer	0.000542	0.000549	CcSEcCtD
Methylphenidate—Feeling abnormal—Fluorouracil—skin cancer	0.000526	0.000532	CcSEcCtD
Methylphenidate—Diarrhoea—Dactinomycin—skin cancer	0.000524	0.00053	CcSEcCtD
Methylphenidate—Vomiting—Bleomycin—skin cancer	0.000522	0.000528	CcSEcCtD
Methylphenidate—Anaemia—Docetaxel—skin cancer	0.000521	0.000528	CcSEcCtD
Methylphenidate—Rash—Bleomycin—skin cancer	0.000517	0.000524	CcSEcCtD
Methylphenidate—Dermatitis—Bleomycin—skin cancer	0.000517	0.000523	CcSEcCtD
Methylphenidate—Hypersensitivity—Temozolomide—skin cancer	0.00051	0.000516	CcSEcCtD
Methylphenidate—Urticaria—Fluorouracil—skin cancer	0.000507	0.000513	CcSEcCtD
Methylphenidate—Syncope—Docetaxel—skin cancer	0.000506	0.000512	CcSEcCtD
Methylphenidate—Leukopenia—Docetaxel—skin cancer	0.000505	0.000511	CcSEcCtD
Methylphenidate—Body temperature increased—Fluorouracil—skin cancer	0.000504	0.00051	CcSEcCtD
Methylphenidate—Palpitations—Docetaxel—skin cancer	0.000498	0.000505	CcSEcCtD
Methylphenidate—Asthenia—Temozolomide—skin cancer	0.000497	0.000503	CcSEcCtD
Methylphenidate—Loss of consciousness—Docetaxel—skin cancer	0.000496	0.000502	CcSEcCtD
Methylphenidate—Cough—Docetaxel—skin cancer	0.000492	0.000498	CcSEcCtD
Methylphenidate—Pruritus—Temozolomide—skin cancer	0.00049	0.000496	CcSEcCtD
Methylphenidate—Convulsion—Docetaxel—skin cancer	0.000489	0.000495	CcSEcCtD
Methylphenidate—Nausea—Bleomycin—skin cancer	0.000487	0.000494	CcSEcCtD
Methylphenidate—Hypertension—Docetaxel—skin cancer	0.000487	0.000493	CcSEcCtD
Methylphenidate—Vomiting—Dactinomycin—skin cancer	0.000487	0.000493	CcSEcCtD
Methylphenidate—Rash—Dactinomycin—skin cancer	0.000483	0.000489	CcSEcCtD
Methylphenidate—Myalgia—Docetaxel—skin cancer	0.00048	0.000486	CcSEcCtD
Methylphenidate—Chest pain—Docetaxel—skin cancer	0.00048	0.000486	CcSEcCtD
Methylphenidate—Arthralgia—Docetaxel—skin cancer	0.00048	0.000486	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000477	0.000483	CcSEcCtD
Methylphenidate—Diarrhoea—Temozolomide—skin cancer	0.000474	0.00048	CcSEcCtD
Methylphenidate—Hypersensitivity—Fluorouracil—skin cancer	0.00047	0.000476	CcSEcCtD
Methylphenidate—Dry mouth—Docetaxel—skin cancer	0.00047	0.000476	CcSEcCtD
Methylphenidate—Confusional state—Docetaxel—skin cancer	0.000464	0.00047	CcSEcCtD
Methylphenidate—Anaphylactic shock—Docetaxel—skin cancer	0.00046	0.000466	CcSEcCtD
Methylphenidate—Oedema—Docetaxel—skin cancer	0.00046	0.000466	CcSEcCtD
Methylphenidate—Dizziness—Temozolomide—skin cancer	0.000458	0.000463	CcSEcCtD
Methylphenidate—Infection—Docetaxel—skin cancer	0.000457	0.000463	CcSEcCtD
Methylphenidate—Nausea—Dactinomycin—skin cancer	0.000455	0.00046	CcSEcCtD
Methylphenidate—Shock—Docetaxel—skin cancer	0.000453	0.000459	CcSEcCtD
Methylphenidate—Nervous system disorder—Docetaxel—skin cancer	0.000451	0.000457	CcSEcCtD
Methylphenidate—Pruritus—Fluorouracil—skin cancer	0.000451	0.000457	CcSEcCtD
Methylphenidate—Thrombocytopenia—Docetaxel—skin cancer	0.000451	0.000456	CcSEcCtD
Methylphenidate—Tachycardia—Docetaxel—skin cancer	0.000449	0.000455	CcSEcCtD
Methylphenidate—Skin disorder—Docetaxel—skin cancer	0.000447	0.000453	CcSEcCtD
Methylphenidate—Vomiting—Temozolomide—skin cancer	0.00044	0.000446	CcSEcCtD
Methylphenidate—Anorexia—Docetaxel—skin cancer	0.000439	0.000444	CcSEcCtD
Methylphenidate—Rash—Temozolomide—skin cancer	0.000436	0.000442	CcSEcCtD
Methylphenidate—Diarrhoea—Fluorouracil—skin cancer	0.000436	0.000442	CcSEcCtD
Methylphenidate—Dermatitis—Temozolomide—skin cancer	0.000436	0.000441	CcSEcCtD
Methylphenidate—Headache—Temozolomide—skin cancer	0.000434	0.000439	CcSEcCtD
Methylphenidate—Dizziness—Fluorouracil—skin cancer	0.000422	0.000427	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000419	0.000425	CcSEcCtD
Methylphenidate—Insomnia—Docetaxel—skin cancer	0.000416	0.000422	CcSEcCtD
Methylphenidate—Paraesthesia—Docetaxel—skin cancer	0.000413	0.000419	CcSEcCtD
Methylphenidate—Nausea—Temozolomide—skin cancer	0.000411	0.000416	CcSEcCtD
Methylphenidate—Dyspnoea—Docetaxel—skin cancer	0.00041	0.000416	CcSEcCtD
Methylphenidate—Somnolence—Docetaxel—skin cancer	0.000409	0.000414	CcSEcCtD
Methylphenidate—Vomiting—Fluorouracil—skin cancer	0.000406	0.000411	CcSEcCtD
Methylphenidate—Dyspepsia—Docetaxel—skin cancer	0.000405	0.00041	CcSEcCtD
Methylphenidate—Rash—Fluorouracil—skin cancer	0.000402	0.000407	CcSEcCtD
Methylphenidate—Dermatitis—Fluorouracil—skin cancer	0.000402	0.000407	CcSEcCtD
Methylphenidate—Decreased appetite—Docetaxel—skin cancer	0.0004	0.000405	CcSEcCtD
Methylphenidate—Headache—Fluorouracil—skin cancer	0.0004	0.000405	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Docetaxel—skin cancer	0.000397	0.000402	CcSEcCtD
Methylphenidate—Fatigue—Docetaxel—skin cancer	0.000397	0.000402	CcSEcCtD
Methylphenidate—Pain—Docetaxel—skin cancer	0.000394	0.000399	CcSEcCtD
Methylphenidate—Constipation—Docetaxel—skin cancer	0.000394	0.000399	CcSEcCtD
Methylphenidate—Feeling abnormal—Docetaxel—skin cancer	0.000379	0.000384	CcSEcCtD
Methylphenidate—Nausea—Fluorouracil—skin cancer	0.000379	0.000384	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Docetaxel—skin cancer	0.000376	0.000381	CcSEcCtD
Methylphenidate—Body temperature increased—Docetaxel—skin cancer	0.000364	0.000368	CcSEcCtD
Methylphenidate—Abdominal pain—Docetaxel—skin cancer	0.000364	0.000368	CcSEcCtD
Methylphenidate—Hypersensitivity—Docetaxel—skin cancer	0.000339	0.000343	CcSEcCtD
Methylphenidate—Asthenia—Docetaxel—skin cancer	0.00033	0.000334	CcSEcCtD
Methylphenidate—Pruritus—Docetaxel—skin cancer	0.000326	0.00033	CcSEcCtD
Methylphenidate—Diarrhoea—Docetaxel—skin cancer	0.000315	0.000319	CcSEcCtD
Methylphenidate—Dizziness—Docetaxel—skin cancer	0.000304	0.000308	CcSEcCtD
Methylphenidate—Vomiting—Docetaxel—skin cancer	0.000293	0.000296	CcSEcCtD
Methylphenidate—Rash—Docetaxel—skin cancer	0.00029	0.000294	CcSEcCtD
Methylphenidate—Dermatitis—Docetaxel—skin cancer	0.00029	0.000294	CcSEcCtD
Methylphenidate—Headache—Docetaxel—skin cancer	0.000288	0.000292	CcSEcCtD
Methylphenidate—Nausea—Docetaxel—skin cancer	0.000273	0.000277	CcSEcCtD
